How on-the-wrist sleep apnea detection works

Original Article ↗ Hacker News Discussion ↗

Hardware & Feature Segmentation

  • Debate over why sleep apnea detection is limited to Apple Watch Series 9/10 (and not even Ultra 1).
  • One side argues it’s largely artificial segmentation, similar to Apple Intelligence being limited to newer iPhones despite cloud processing.
  • Others point to plausible technical reasons: newer accelerometers, need for additional sensors (SpO2, possibly temperature), higher compute, and battery constraints.
  • Some accept Apple’s pattern of withholding technically-possible features if they degrade user experience (speed, battery).

Sensors, Patents & FDA Status

  • Disagreement over whether apnea detection uses only the accelerometer or also blood oxygen and temperature.
  • US models have SpO2 disabled due to a patent dispute; non-US specs still list it, suggesting hardware is present but blocked.
  • Speculation that Apple could use optical data “internally” without exposing explicit SpO2 readings.
  • Feature is not yet live; commenters say it’s pending FDA clearance.

Accuracy & Role of Watch-Based Detection

  • Dedicated PAT-based devices and full sleep studies use multiple channels (SpO2, ECG, airflow, belts, video) and even then can be ambiguous.
  • Many view watch detection as a screening tool akin to AFib alerts, not a definitive diagnosis.
  • Concerns that intermittent SpO2 sampling on watches may miss short desaturations, though long-term nightly data could still be useful.

Oxygen Monitoring & Battery Life

  • Some wish for continuous nocturnal SpO2, but others cite battery and regulatory limits.
  • Apple aggressively duty-cycles sensors to hit ~18‑hour life; critics argue Apple over-prioritizes screen/CPU over multi-day health tracking.
  • Users share charging strategies (during shower, coffee, commute) and note better life on Ultra models.

CPAP Access, Regulation & Market Structure

  • Strong frustration with gatekeeping: prescriptions, insurance delays, repeated studies, and cost.
  • Some advocate OTC, mass-market CPAPs with user-adjustable pressure, arguing risks of self-titration are lower than untreated apnea.
  • Others stress the need for regulation and physician oversight, citing complexity of correct use and examples like Philips’ foam recall and CPAP-related deaths.
  • Side discussion on at-home tests, online vendors, and using hidden “service menus” to tweak settings.

Alternative Remedies & Fringe Ideas

  • Mouth taping and a 19th‑century “shut your mouth” book spark heavy skepticism; critics emphasize lack of modern evidence and safety concerns.
  • Another commenter’s claim that briefly increasing head blood pressure can “100% fix” apnea and myopia is widely challenged as implausible.
  • Cheap off-brand watches with SpO2 are warned against due to reports of obviously fake readings.